The Role of NLRP3 Inflammasome in Diabetes: A Review
Author Information
Author(s): Tan Yi, Chen Shaotao, Gao Tianjiao, Wang Sixian, Zhou Xinfeng, Liu Mingjun
Primary Institution: Changchun University of Chinese Medicine
Hypothesis
This study seeks to investigate the role of NLRP3 inflammasome in diabetes over the past ten years.
Conclusion
The study identifies key trends and hotspots regarding the role of NLRP3 inflammasome in diabetes, suggesting future research directions.
Supporting Evidence
- China, the United States, and Italy contributed the majority of records in the literature.
- Harbin Medical University, Nanjing Medical University, and Central South University are the top three most productive institutions.
- Key topics in the field include heart damage, caspase 1 activation, NLRP3, and diabetic kidney disease.
Takeaway
Researchers looked at many studies about a protein called NLRP3 and how it affects diabetes, finding important trends and topics for future research.
Methodology
A literature search was conducted using the SCI-E database, and data was analyzed using bibliometric software tools.
Limitations
The study focused on the WoS database and only included English-language articles, potentially omitting relevant studies.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website